Journal Article

Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations

Lois B. Travis, Charles S. Rabkin, Linda Morris Brown, James M. Allan, Blanche P. Alter, Christine B. Ambrosone, Colin B. Begg, Neil Caporaso, Stephen Chanock, Angela DeMichele, William Douglas Figg, Mary K. Gospodarowicz, Eric J. Hall, Michie Hisada, Peter Inskip, Ruth Kleinerman, John B. Little, David Malkin, Andrea K. Ng, Kenneth Offit, Ching-Hon Pui, Leslie L. Robison, Nathaniel Rothman, Peter G. Shields, Louise Strong, Toshiyasu Taniguchi, Margaret A. Tucker and Mark H. Greene

in JNCI: Journal of the National Cancer Institute

Volume 98, issue 1, pages 15-25
Published in print January 2006 | ISSN: 0027-8874
Published online January 2006 | e-ISSN: 1460-2105 | DOI:
Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations

Show Summary Details


Cancer survivors constitute 3.5% of the United States population, but second primary malignancies among this high-risk group now account for 16% of all cancer incidence. Although few data currently exist regarding the molecular mechanisms for second primary cancers and other late outcomes after cancer treatment, the careful measurement and documentation of potentially carcinogenic treatments (chemotherapy and radiotherapy) provide a unique platform for in vivo research on gene–environment interactions in human carcinogenesis. We review research priorities identified during a National Cancer Institute (NCI)–sponsored workshop entitled “Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers.” These priorities include 1) development of a national research infrastructure for studies of cancer survivorship; 2) creation of a coordinated system for biospecimen collection; 3) development of new technology, bioinformatics, and biomarkers; 4) design of new epidemiologic methods; and 5) development of evidence-based clinical practice guidelines. Many of the infrastructure resources and design strategies that would facilitate research in this area also provide a foundation for the study of other important nonneoplastic late effects of treatment and psychosocial concerns among cancer survivors. These research areas warrant high priority to promote NCI's goal of eliminating pain and suffering related to cancer.

Journal Article.  10215 words.  Illustrated.

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.